Lower Entresto Doses Suffice in the Real World

(MedPage Today) -- Heart failure patients unable to reach the target dose of angiotensin receptor/neprilysin inhibitor (ARNI) therapy still reaped gains in health status a year later, according to a post hoc analysis of PROVE-HF.
People taking...